Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Plasma and cerebrospinal fluid inflammatory markers and human aggression
    Published on 2023-02-16
    3 years ago
  • A pilot randomized controlled trial of ketamine in Borderline Personality Disorder
    Published on 2023-02-16
    3 years ago
  • mGluR5 in hippocampal CA1 pyramidal neurons mediates stress-induced anxiety-like behavior
    Published on 2023-02-15
    3 years ago
  • Association of default-mode network neurotransmitters and inter-network functional connectivity in first episode psychosis
    Published on 2023-02-13
    3 years ago
  • William T. McKinney, Jr., MD 1937–2022
    Published on 2023-02-13
    3 years ago
  • Identifying novel proteins underlying loneliness by integrating GWAS summary data with human brain proteomes
    Published on 2023-02-07
    3 years ago
  • Activation of GABAB receptors in central amygdala attenuates activity of PKCδ + neurons and suppresses punishment-resistant alcohol self-administration in rats
    Published on 2023-02-03
    3 years ago
« Previous 1 … 107 108 109 110 111 … 143 Next »
Journal of Psychopharmacology
  • Designer benzodiazepines’ pharmacological effects and potencies: How to find the information
    Published on 2020-01-23
    6 years ago
  • The generalizability of clinical and experimental tobacco research: Do exclusion criteria impact men and women differently?
    Published on 2020-01-22
    6 years ago
  • Chronic social defeat stress: Impacts on ethanol-induced stimulation, corticosterone response, and brain monoamine levels
    Published on 2020-01-22
    6 years ago
  • Plasma monoamines change under dopamine supersensitivity psychosis in patients with schizophrenia: A comparison with first-episode psychosis
    Published on 2020-01-21
    6 years ago
  • Lights and shadows of schizophrenia therapy research: Lessons from oral risperidone and olanzapine
    Published on 2020-01-21
    6 years ago
  • Decreased nuclear distribution nudE-like 1 enzyme activity in an animal model with dysfunctional disrupted-in-schizophrenia 1 signaling featuring aberrant neurodevelopment and amphetamine-supersensitivity
    Published on 2020-01-09
    6 years ago
  • Cannabinoid receptor type 1 in the bed nucleus of the stria terminalis modulates cardiovascular responses to stress via local N-methyl-D-aspartate receptor/neuronal nitric oxide synthase/soluble guanylate cyclase/protein kinase G signaling
    Published on 2020-01-08
    6 years ago
« Previous 1 … 107 108 109 110 111 … 134 Next »
European Neuropsychopharmacology
  • P.120 Prenatal stress induces sex-specific behavioural and excitatory/inhibitory balance alterations in adult rats
    Published on 2021-02-26
    5 years ago
  • P.207 Sex differences in cocaine consumption vulnerability induced by early-life stress in mice
    Published on 2021-02-26
    5 years ago
  • P.118 Changes of the excitability of trigeminal ganglion neurons under noradrenergic modulation of calcium currents
    Published on 2021-02-26
    5 years ago
  • P.208 Vulnerability to chronic stress in rats with low positive affectivity and high expression of hedonic behaviour
    Published on 2021-02-26
    5 years ago
  • P.105 Enhanced coupling of the 5-HT2A receptor with Gαi1-protein in post-mortem frontal cortex of subjects with schizophrenia
    Published on 2021-02-26
    5 years ago
  • P.209 Childhood trauma and dysregulation of multiple biological stress systems in adulthood: results from the NESDA cohort
    Published on 2021-02-26
    5 years ago
  • Early intervention in psychosis during the COVID-19 pandemic: Maudsley recommendations
    Published on 2021-02-26
    5 years ago
« Previous 1 … 107 108 109 110 111 … 155 Next »

   Pharma Pub